NCT05179239 2025-04-15
A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3 Terminated
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Shanghai Bovax Biotechnology Co., Ltd.
GOG Foundation
National Cancer Institute (NCI)
Asan Medical Center
Japan Clinical Oncology Group
M.D. Anderson Cancer Center
Columbia University
Duke University
GOG Foundation
UNICANCER